Free Trial

AngioDynamics (ANGO) SEC Filings & 10K Form

$7.18
+0.23 (+3.31%)
(As of 04:15 PM ET)

Recent AngioDynamics SEC Filings

DateFilerForm TypeView
07/16/2024
6:22 AM
AngioDynamics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/16/2024
6:15 AM
AngioDynamics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/09/2024
4:08 PM
AngioDynamics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/08/2024
3:30 PM
AngioDynamics (Issuer)
Clemmer James C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/04/2024
6:30 AM
AngioDynamics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/04/2024
7:49 PM
AngioDynamics (Issuer)
Trowbridge Stephen A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2024
3:24 PM
AngioDynamics (Subject)
MILLENNIUM MANAGEMENT LLC (Filed by)
Form SC 13G/A
01/23/2024
3:14 PM
AngioDynamics (Subject)
BlackRock Inc. (Filed by)
Form SC 13G/A
01/22/2024
12:31 PM
AngioDynamics (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
01/22/2024
6:30 AM
AngioDynamics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/11/2024
6:30 AM
AngioDynamics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2024
3:47 PM
AngioDynamics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
01/05/2024
6:15 AM
AngioDynamics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/15/2023
7:02 PM
AngioDynamics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/07/2023
7:03 AM
AngioDynamics (Filer)
Form DEFA14A
10/06/2023
1:34 PM
AngioDynamics (Subject)
BlackRock Inc. (Filed by)
Form SC 13G/A
10/05/2023
4:15 PM
AngioDynamics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/04/2023
6:15 AM
AngioDynamics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/28/2023
2:14 PM
AngioDynamics (Filer)
Form DEFA14A
09/28/2023
2:10 PM
AngioDynamics (Filer)
Form DEF 14A
09/21/2023
8:28 PM
AngioDynamics (Issuer)
Trowbridge Stephen A (Reporting)
Form 4/A
09/21/2023
8:17 PM
AngioDynamics (Issuer)
Centea Scott (Reporting)
Form 4/A
09/21/2023
8:23 PM
AngioDynamics (Issuer)
Helsel Dave (Reporting)
Form 4/A
09/21/2023
8:07 PM
AngioDynamics (Issuer)
Clemmer James C (Reporting)
Form 4/A
09/21/2023
8:12 PM
AngioDynamics (Issuer)
Campbell Chad Thomas (Reporting)
Form 4/A
09/12/2023
3:22 PM
AngioDynamics (Subject)
MILLENNIUM MANAGEMENT LLC (Filed by)
Form SC 13G
07/26/2023
8:32 PM
AngioDynamics (Issuer)
Trowbridge Stephen A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/26/2023
8:32 PM
AngioDynamics (Issuer)
Centea Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/26/2023
8:32 PM
AngioDynamics (Issuer)
Campbell Chad Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/26/2023
8:32 PM
AngioDynamics (Issuer)
Helsel Dave (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/26/2023
8:32 PM
AngioDynamics (Issuer)
Clemmer James C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/25/2023
6:06 PM
AngioDynamics (Issuer)
Campbell Chad Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/25/2023
6:06 PM
AngioDynamics (Issuer)
Piccinini Laura (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/25/2023
6:06 PM
AngioDynamics (Issuer)
Centea Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/25/2023
6:07 PM
AngioDynamics (Issuer)
Helsel Dave (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/25/2023
6:07 PM
AngioDynamics (Issuer)
Clemmer James C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/25/2023
6:07 PM
AngioDynamics (Issuer)
Trowbridge Stephen A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/24/2023
3:15 PM
AngioDynamics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/21/2023
8:11 PM
AngioDynamics (Issuer)
Licitra Karen A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/21/2023
8:11 PM
AngioDynamics (Issuer)
Tarnoff Michael E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/21/2023
8:11 PM
AngioDynamics (Issuer)
Auen Eileen O'Shea (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Who’s partnering with Nvidia next? (Ad)

Nvidia's been quietly pivoting to another, potentially lucrative business. Nvidia's own CEO, Jensen Huang, believes Big Tech is going to spend over $1 trillion on this part of the business over the next four years.

Find out more details on these three critical Nvidia partners immediately.
07/21/2023
8:11 PM
AngioDynamics (Issuer)
REED JAN STERN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/21/2023
8:11 PM
AngioDynamics (Issuer)
DONNELLY HOWARD W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/21/2023
8:11 PM
AngioDynamics (Issuer)
JOHNSON WESLEY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/21/2023
8:11 PM
AngioDynamics (Issuer)
Campbell Chad Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/21/2023
8:11 PM
AngioDynamics (Issuer)
Meteny Dennis S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/21/2023
8:11 PM
AngioDynamics (Issuer)
Clemmer James C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/21/2023
8:11 PM
AngioDynamics (Issuer)
Centea Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/21/2023
8:11 PM
AngioDynamics (Issuer)
Helsel Dave (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/21/2023
8:11 PM
AngioDynamics (Issuer)
Trowbridge Stephen A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/21/2023
8:11 PM
AngioDynamics (Issuer)
Piccinini Laura (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/21/2023
7:04 PM
AngioDynamics (Issuer)
Burgess Lorinda (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/21/2023
7:06 PM
AngioDynamics (Issuer)
Burgess Lorinda (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/18/2023
7:13 PM
AngioDynamics (Issuer)
Helsel Dave (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/18/2023
7:13 PM
AngioDynamics (Issuer)
Centea Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/18/2023
7:13 PM
AngioDynamics (Issuer)
Campbell Chad Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/18/2023
7:13 PM
AngioDynamics (Issuer)
Clemmer James C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/18/2023
7:13 PM
AngioDynamics (Issuer)
Trowbridge Stephen A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:ANGO) was last updated on 7/19/2024 by MarketBeat.com Staff

From Our Partners